Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
Giovanni Battista Migliori, Florian M. Marx, Nicolino Ambrosino, et al.
The International Journal of Tuberculosis and Lung Disease (2021) Vol. 25, Iss. 10, pp. 797-813
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Tuberculosis and COVID-19 co-infection: description of the global cohort

European Respiratory Journal (2021) Vol. 59, Iss. 3, pp. 2102538-2102538
Open Access | Times Cited: 129
Drug resistant TB – latest developments in epidemiology, diagnostics and management
Simon Tiberi, Natasa Utjesanovic, Jessica Galvin, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. S20-S25
Open Access | Times Cited: 83
Post-TB health and wellbeing
Rebecca Nightingale, Ffion Carlin, Jamilah Meghji, et al.
The International Journal of Tuberculosis and Lung Disease (2023) Vol. 27, Iss. 4, pp. 248-283
Open Access | Times Cited: 67
Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people
Olena Ivanova, Verena Hoffmann, Christoph Lange, et al.
European Respiratory Review (2023) Vol. 32, Iss. 168, pp. 220221-220221
Open Access | Times Cited: 48
Clinical standards for the diagnosis, treatment and prevention of TB infection
Giovanni Battista Migliori, Shishi Wu, Alberto Matteelli, et al.
The International Journal of Tuberculosis and Lung Disease (2022) Vol. 26, Iss. 3, pp. 190-205
Open Access | Times Cited: 55
Clinical standards for the dosing and management of TB drugs
Jan‐Willem C. Alffenaar, Sophie L. Stocker, Lina Davies Forsman, et al.
The International Journal of Tuberculosis and Lung Disease (2022) Vol. 26, Iss. 6, pp. 483-499
Open Access | Times Cited: 49
Residual respiratory disability after successful treatment of pulmonary tuberculosis: a systematic review and meta-analysis
Joshua Taylor, Mayara Lisboa Bastos, Sophie Lachapelle-Chisholm, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101979-101979
Open Access | Times Cited: 33
Post-tuberculosis sequelae in children and adolescents: a systematic review
Vanessa Igbokwe, Lisa C Ruby, Ayten Sultanli, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 4, pp. e138-e150
Closed Access | Times Cited: 31
Perspectives from the 2nd International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomes
Brian Allwood, Rebecca Nightingale, Gino Agbota, et al.
Deleted Journal (2024) Vol. 1, Iss. 3, pp. 111-123
Open Access | Times Cited: 12
Pulmonary rehabilitation in patients with post-tuberculosis lung disease: a prospective multicentre study
Denise Rossato Silva, Fernanda Carvalho de Queiroz Mello, Tassiana Rodrigues dos Santos Galvão, et al.
Archivos de Bronconeumología (2025)
Closed Access | Times Cited: 1
Tuberculosis
Anete Trajman, Jonathon R. Campbell, Tenzin Kunor, et al.
The Lancet (2025) Vol. 405, Iss. 10481, pp. 850-866
Closed Access | Times Cited: 1
Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: A systematic review and meta-analysis
Elizabeth Maleche‐Obimbo, Mercy Odhiambo, Lynette Njeri, et al.
PLOS Global Public Health (2022) Vol. 2, Iss. 12, pp. e0000805-e0000805
Open Access | Times Cited: 36
First and Second-Line Anti-Tuberculosis Drug-Resistance Patterns in Pulmonary Tuberculosis Patients in Zambia
Ngula Monde, Musso Munyeme, Gershom Chongwe, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 166-166
Open Access | Times Cited: 22
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort
Nicolás Casco, Alberto Levi Jorge, Domingo Palmero, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 5, pp. 2300925-2300925
Open Access | Times Cited: 21
Tuberculosis in older adults: challenges and best practices in the Western Pacific Region
Alvin Kuo Jing Teo, Fukushi Morishita, Tauhid Islam, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 36, pp. 100770-100770
Open Access | Times Cited: 20
Clinical standards for the management of adverse effects during treatment for TB
Kasha P. Singh, Ana Cláudia Carvalho, Rosella Centis, et al.
The International Journal of Tuberculosis and Lung Disease (2023) Vol. 27, Iss. 7, pp. 506-519
Open Access | Times Cited: 17
Interventions to prevent post-tuberculosis sequelae: a systematic review and meta-analysis
Kefyalew Addis Alene, Lucas Hertzog, Beth Gilmour, et al.
EClinicalMedicine (2024) Vol. 70, pp. 102511-102511
Open Access | Times Cited: 8
Tuberkulose im Erwachsenenalter
Tom Schaberg, Folke Brinkmann, Cornelia Feiterna‐Sperling, et al.
Pneumologie (2022) Vol. 76, Iss. 11, pp. 727-819
Open Access | Times Cited: 24
Difficulties in distinguishing silicosis and pulmonary tuberculosis in silica‐exposed gold miners: A report of four cases
Botembetume Maboso, Jim te Water Naude, David Rees, et al.
American Journal of Industrial Medicine (2023) Vol. 66, Iss. 4, pp. 339-348
Open Access | Times Cited: 14
Long term management of people with post-tuberculosis lung disease
Wan Seo, Hyung Woo Kim, Ju Sang Kim, et al.
The Korean Journal of Internal Medicine (2024) Vol. 39, Iss. 1, pp. 7-24
Open Access | Times Cited: 5
Clinical standards for drug-susceptible pulmonary TB
Onno W. Akkerman, Raquel Duarte, Simon Tiberi, et al.
The International Journal of Tuberculosis and Lung Disease (2022) Vol. 26, Iss. 7, pp. 592-604
Open Access | Times Cited: 19
Immunologic and imaging signatures in post tuberculosis lung disease
S. Singh, B W Allwood, TL Chiyaka, et al.
Tuberculosis (2022) Vol. 136, pp. 102244-102244
Open Access | Times Cited: 19
Healthcare Utilization After Respiratory Tuberculosis: A Controlled Interrupted Time Series Analysis
Kamila Romanowski, Michael R. Law, Mohammad Ehsanul Karim, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 6, pp. 883-891
Open Access | Times Cited: 11
The Tuberculosis Sentinel Research Network (TB-SRN) of the International epidemiology Databases to Evaluate AIDS (IeDEA): protocol for a prospective cohort study in Africa, Southeast Asia and Latin America
Leslie A. Enane, Stephany N. Duda, Thida Chanyachukul, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e079138-e079138
Open Access | Times Cited: 4
Incidence and prevalence of chronic pulmonary aspergillosis in patients with post‐tuberculosis lung abnormality: Results from a community survey in North India
Soundappan Kathirvel, Inderpaul Singh Sehgal, Nidhi Prabhakar, et al.
Mycoses (2024) Vol. 67, Iss. 3
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top